ILF3

Interleukin enhancer-binding factor 3 · Q12906 · ILF3 on Sugi Atlas →

90 patent compounds predicted against ILF3, 55 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Sepantronium (SCHEMBL727997)	1.00	1/20
Sepantronium (SCHEMBL29493286)	1.00	1/20
Sepantronium (SCHEMBL2814447)	0.98	1/20
Sepantronium (SCHEMBL2814857)	0.98	1/20
Bromide (SCHEMBL15062823)	0.79	1/20
SCHEMBL6190071	0.74	1/20
Sepantronium (SCHEMBL16584072)	0.73	1/20
Sepantronium (SCHEMBL29379252)	0.73	1/20
SCHEMBL6190207	0.72	1/20
Sepantronium (SCHEMBL6188375)	0.71	1/20
Sepantronium (SCHEMBL29464041)	0.71	1/20
SCHEMBL21614164	0.70	1/20
Hydrochloric Acid (SCHEMBL6188651)	0.69	1/20
SCHEMBL6188546	0.64	1/20
Bromide (SCHEMBL22413046)	0.61	1/20
SCHEMBL26354926	0.59	1/20
SCHEMBL6187056	0.58	1/20
SCHEMBL6189812	0.57	1/20
SCHEMBL6191935	0.57	1/20
SCHEMBL6189328	0.55	1/20

Clinical trials — most relevant to ILF3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room	PHASE2/PHASE3	COMPLETED
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)	PHASE1	NOT_YET_RECRUITING
Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids	PHASE1	COMPLETED
Autophagy in Systemic Lupus Erythematosus	nan	UNKNOWN
Genetic Variation in TRAF3IP2 (rs13190932)	nan	RECRUITING
NCF Gene & TNFSF4 in SLE Patients	nan	UNKNOWN
Immune Interactions in Severe Asthma	nan	COMPLETED
Detection of IKZF1 Deletion Mutation in Patients With Acute Lymphoblastic Leukemia and Its Impact in Therapy	nan	UNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry Bad Cholesterol in the Blood	nan	COMPLETED
RORC Genetic Polymorphism of Rheumatoid Arthritis	nan	COMPLETED
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient	nan	RECRUITING
Genetic Studies of Inflammatory Bowel Disease	nan	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C	nan	COMPLETED
Effect of Periodontal Treatment on Inflammasome Proteins in Periodontal Diseases	nan	UNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia	nan	UNKNOWN
Diagnosis of Inflammatory Bowel Disease	nan	NOT_YET_RECRUITING
Characterizing the Role of Pain Sensitivity in Acute to Persistent Low Back Pain	nan	COMPLETED
Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer	nan	UNKNOWN
The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery	nan	COMPLETED
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients	nan	ACTIVE_NOT_RECRUITING
Novel Biomarkers in Inflammatory Bowel Disease	nan	COMPLETED
Evaluation of the Predictive Effect of Inflammatory Markers in MI Patients	nan	UNKNOWN
Prognostic Value of Protein IMP3 Expression in Cervical Cancer	nan	COMPLETED
Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.	nan	COMPLETED
EKLF Gene Expression in β-thalassemia	nan	NOT_YET_RECRUITING
Study of Proteins in Head and Neck Cancer Cells	nan	COMPLETED
RNA Cloning and Visualization in Human Atherosclerosis	nan	COMPLETED
JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a ILF3 binder may also engage these)

Protein	Name	Similarity
Q9Z1X4	—	1.000	Q9Z1X4 →
Q9JIL3	—	1.000	Q9JIL3 →
Q6GL57	—	0.984	Q6GL57 →
Q6NXA4	—	0.983	Q6NXA4 →
Q6PCR6	—	0.979	Q6PCR6 →
Q6DD04	—	0.978	Q6DD04 →
Q91550	—	0.978	Q91550 →
Q5U231	—	0.976	Q5U231 →
Q6GPM1	—	0.976	Q6GPM1 →
Q6DCD0	—	0.976	Q6DCD0 →
Q562A2	—	0.974	Q562A2 →
Q01826	—	0.971	Q01826 →
Q9JKU6	—	0.968	Q9JKU6 →
Q6DEE7	—	0.967	Q6DEE7 →
Q4KUS2	—	0.967	Q4KUS2 →
Q8UUW7	—	0.966	Q8UUW7 →
Q8VI24	—	0.966	Q8VI24 →
A2VDN6	—	0.966	A2VDN6 →
Q99569	—	0.965	Q99569 →
ZFR	Zinc finger RNA-binding protein	0.965	landscape →
Q60611	—	0.964	Q60611 →
Q9UQB3	—	0.964	Q9UQB3 →
CTNND1	Catenin delta-1	0.964	landscape →
Q9UPW6	—	0.964	Q9UPW6 →
YTHDF1	YTH domain-containing family protein 1	0.963	landscape →
Q921D9	—	0.963	Q921D9 →
Q5REX3	—	0.963	Q5REX3 →
P22682	—	0.963	P22682 →
O88532	—	0.963	O88532 →
Q8C092	—	0.963	Q8C092 →